MEDTOX Scientific Inc. (MTOX) Reports In-Line Q4 EPS
MEDTOX Scientific Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.09, in-line with the analyst estimate of $0.09. Revenue for the quarter came in at $25 million versus the consensus estimate of $24.49 million.
You May Also Be Interested In
- Vantiv (VNTV) Reports In-Line Q2 EPS; Raises Outlook
- Kennametal, Inc. (KMT) Misses Q4 EPS by 14c, Offers Guidance (Earlier)
- Pentair, Inc. (PNR) Tops Q2 EPS by 1c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!